CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-9.4%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.79B
AUM Growth
+$2.79B
(-9.3%)
Cap. Flow
+$60.3M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
57.47%
Holding
43
New
4
Increased
14
Reduced
10
Closed
3
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$89.8M |
| 2 |
Medtronic
MDT
|
$70.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
$48.5M |
| 4 |
Globus Medical
GMED
|
$36M |
| 5 |
Tenet Healthcare
THC
|
$29.7M |
Top Sells
| 1 |
Sanofi
SNY
|
$67.1M |
| 2 |
Quanterix
QTRX
|
$58.4M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$51.2M |
| 4 |
GSK
GSK
|
$45.3M |
| 5 |
Exelixis
EXEL
|
$27.3M |
Sector Composition
| 1 | Healthcare | 96.13% |
| 2 | Consumer Staples | 2.51% |
| 3 | Consumer Discretionary | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Universal Health Services
UHS
$11.6B
| $251M | 8.29% | 2,000,000 +75,000 | +4% | +$9.43M |
|
|
2
Tenet Healthcare
THC
$16.3B
| $240M | 7.93% | 3,650,000 +450,000 | +14% | +$29.7M |
|
|
3
Zimmer Biomet
ZBH
$21B
| $208M | 6.84% | 1,850,000 +800,000 | +76% | +$89.8M |
|
4
Viatris
VTRS
$12.3B
| $197M | 6.5% | 20,000,000 -2,500,000 | -11% | -$24.7M |
|
|
5
Sanofi
SNY
$121B
| $148M | 4.86% | 2,750,000 -1,250,000 | -31% | -$67.1M |
|
|
6
Medtronic
MDT
$119B
| $118M | 3.87% | 1,500,000 +900,000 | +150% | +$70.5M |
|
|
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
| $116M | 3.81% | 5,200,000 -2,300,000 | -31% | -$51.2M |
|
8
Baxter International
BAX
$12.7B
| $113M | 3.73% | 3,000,000 | – | – |
|
9
Myriad Genetics
MYGN
$593M
| $106M | 3.51% | 6,635,000 | – | – |
|
10
Teva Pharmaceuticals
TEVA
$21.1B
| $104M | 3.41% | 10,150,000 +1,650,000 | +19% | +$16.8M |
|
|
11
GSK
GSK
$79.9B
| $103M | 3.41% | 2,850,000 -1,250,000 | -30% | -$45.3M |
|
12
Ionis Pharmaceuticals
IONS
$6.79B
| $102M | 3.36% | 2,250,000 -250,000 | -10% | -$11.3M |
|
|
13
Sarepta Therapeutics
SRPT
$1.78B
| $97M | 3.2% | 800,000 +400,000 | +100% | +$48.5M |
|
14
Select Medical
SEM
$1.61B
| $85.9M | 2.83% | 3,400,000 -650,000 | -16% | -$16.4M |
|
|
15
Globus Medical
GMED
$8.27B
| $85.6M | 2.82% | 1,725,000 +725,000 | +73% | +$36M |
|
16
PTC Therapeutics
PTCT
$3.92B
| $76.2M | 2.51% | 3,400,000 +900,000 | +36% | +$20.2M |
|
17
Brookdale Senior Living
BKD
$1.83B
| $74.5M | 2.46% | 18,000,000 | – | – |
|
|
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $65.3M | 2.15% | 1,500,000 -300,000 | -17% | -$13.1M |
|
19
Dentsply Sirona
XRAY
$2.85B
| $60.3M | 1.99% | 1,765,000 | – | – |
|
20
Perrigo
PRGO
$3.27B
| $59.1M | 1.95% | 1,850,000 -650,000 | -26% | -$20.8M |
|
21
Herbalife
HLF
$1.01B
| $39.9M | 1.31% | 2,850,000 +100,000 | +4% | +$1.4M |
|
|
22
Quanterix
QTRX
$211M
| $34.6M | 1.14% | 1,275,000 -2,150,000 | -63% | -$58.4M |
|
23
Replimune Group
REPL
$422M
| $34.2M | 1.13% | 2,000,000 +450,000 | +29% | +$7.7M |
|
24
ZimVie
ZIMV
$532M
| $30.6M | 1.01% | 3,250,000 | – | – |
|
25
The Beauty Health Co
SKIN
$264M
| $30.1M | 0.99% | 5,000,000 +3,250,000 | +186% | +$19.6M |
|